Mateus Rodrigues de Aguiar
Research Subjects
Research Interests
Mateus Rodrigues de Aguiar has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Lorena Bizarria Neves
Parangaba Campus, Estácio University Center, Senador Fernandes Távora Avenue, 137A-Jóquei Clube, Fortaleza 60510-111, CE, Brazil
1 shared publication - Paulo Iury Gomes Nunes
Universidade Federal do Ceará, Brasil
1 shared publication - Rafaela De Sousa Brito
Federal Institute of Education, Science and Technology of Ceará, Crateús Campus, Av. Dr. Geraldo Barbosa Marques, 567-Venancio, Crateús 63708-260, CE, Brazil
1 shared publication - Stephen Rathinaraj Benjamin
Federal University of Ceará
1 shared publication - Veralice Meireles Sales de Bruin
Universidade Federal do Ceará, Brasil
1 shared publication
Latest Publications
- Open Access
- 27 August 2025
- Published by MDPI AG in Clinical Bioenergetics
- Vol. 1 (1) , 6
Mitochondria, Oxidative Stress, and Psychiatric Disorders: An Integrative Perspective on Brain Bioenergetics
Psychiatric disorders such as major depressive disorder, bipolar disorder, and schizophrenia are now recognized as complex systemic conditions in which mitochondrial dysfunction and oxidative stress are key contributors to their pathophysiology. Mitochondria, beyond their role in ATP synthesis, are critical for calcium regulation, immune responses, and apoptosis, and their impairment affects brain function. This review examines current evidence from transcriptomics, metabolomics, neuroimaging, and preclinical studies, which consistently show disruptions in oxidative phosphorylation, mitochondrial fragmentation, altered mitochondrial DNA, and heightened inflammatory activity across these disorders. We integrate recent advances with the understanding of mitochondrial bioenergetics in the brain, the contribution of redox imbalance to neural dysfunction, the crosstalk between mitochondria and immune mechanisms, and the relevance of these processes to clinical symptoms. Furthermore, we highlight the promise of bioenergetic biomarkers and emerging interventions targeting mitochondrial pathways, including antioxidants, AMPK-SIRT1-PGC-1α axis modulators, physical exercise, and mitoprotective agents. Peripheral metabolic signatures and neuroimaging modalities are also discussed as tools for diagnostic refinement and individualized therapeutic approaches. These insights underscore the centrality of mitochondrial health in psychiatric disease and support the development of precision psychiatry grounded in metabolic phenotyping.
- 27 August 2025
- Published by MDPI AG in Clinical Bioenergetics
- Vol. 1 (1) , 6
Open AccessMitochondria, Oxidative Stress, and Psychiatric Disorders: An Integrative Perspective on Brain Bioenergetics
Psychiatric disorders such as major depressive disorder, bipolar disorder, and schizophrenia are now recognized as complex systemic conditions in which mitochondrial dysfunction and oxidative stress are key contributors to their pathophysiology. Mitochondria, beyond their role in ATP synthesis, are critical for calcium regulation, immune responses, and apoptosis, and their impairment affects brain function. This review examines current evidence from transcriptomics, metabolomics, neuroimaging, and preclinical studies, which consistently show disruptions in oxidative phosphorylation, mitochondrial fragmentation, altered mitochondrial DNA, and heightened inflammatory activity across these disorders. We integrate recent advances with the understanding of mitochondrial bioenergetics in the brain, the contribution of redox imbalance to neural dysfunction, the crosstalk between mitochondria and immune mechanisms, and the relevance of these processes to clinical symptoms. Furthermore, we highlight the promise of bioenergetic biomarkers and emerging interventions targeting mitochondrial pathways, including antioxidants, AMPK-SIRT1-PGC-1α axis modulators, physical exercise, and mitoprotective agents. Peripheral metabolic signatures and neuroimaging modalities are also discussed as tools for diagnostic refinement and individualized therapeutic approaches. These insights underscore the centrality of mitochondrial health in psychiatric disease and support the development of precision psychiatry grounded in metabolic phenotyping.